EUCTR2014-001561-27-BE进行中（未招募）1 期
Vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia: comparing one-hour infusions with bolus injections (the VINCA-study) - The VINCA-study (Vincristine-Induced Neuropathy in Children with Acute lymphoblastic leukemia)
VU university medical center0 个研究点目标入组 90 人开始时间: 2016年5月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •inclusion in DCOG ALL-11/EORTC-CLG 58081/EsPhALL protocol
- •written informed consent;
- •age 2-18 years.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 88
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •patient or parent refusal
- •history of PNP or other pre-existing neurologic conditions before ALL diagnosis;
- •pre-existing severe mental retardation;
- •having parents/ guardians who are unable to communicate in the Dutch/French language.
研究者
相似试验
已完成
不适用
Vincristine-induced peripheral neuropathy in children with childhood cancer: comparing one-hour infusions with short-term infusions (the VINCA-study)childhood cancerPediatric oncology1002432410027655NL-OMON47569Vrije Universiteit Medisch Centrum58
进行中（未招募）
1 期
europathy caused by vincristine in children with leukemia: comparing one-hour infusions with short-term infusionsEUCTR2014-001561-27-NLVU university medical center88
尚未招募
不适用
TO STUDY THE EFFECT OF PERIPHERAL NEUROPATHY DUE TO VINCRISTINE ON FUNCTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIACTRI/2022/09/045215Manjusha Vagal
尚未招募
不适用
Perifere neuropathie als gevolg van vincristine bij kinderen met leukemie: een vergelijking van twee toedieningsvormeAcute lymphoblastic leukemia<br />Peripheral neuropathy<br />Vincristine<br />Chemotherapy<br />NL-OMON29651VU University Medical Center Amsterdam80
已完成
不适用
Chemotherapy Induced Peripheral Neuropathy (CIPN) and Lymphoma Longitudinal Follow-up and Prognostic FactorsLymphomaPeripheral NeuropathyNCT05378256Centre Hospitalier Régional d'Orléans40